Edward Harvey
Chairman of the Board
Dr Harvey has a rich history of collaboration with basic, clinical and engineering scientists. He is a tenured Professor of Surgery at McGill University. He is the Director of the Injury Repair and Rehabilitation program (one of only eight programs that make up the entire institute) at the MUHC-RI with over 100 investigators in his group. He is, or has been, editor-in-chief of the Canadian Journal of Surgery; editorial board member of the Journal of Orthopaedic Trauma and OTA International; chairman of the Research Committee and of the Annual Basic Science Course of the OTA; chair of the Trauma Section at the ORS; and president of the Canadian Orthopaedic Association amongst other national and international positions.
Charles Allan
Director
Charles has a passion for solving problems with MEMS technology. Prior to NXTSENS Microsystems Inc., he completed an M. Eng. at McGill University where he led an engineering team developing high precision MEMS absolute pressure sensors. In his B.Eng., Charles led a team that developed a miniature glaucoma pump. Currently he is leading the commercialization efforts of MY01, leveraging his passions for both business and engineering to ensure optimal user experience and adoption.
Maria Shepherd
Independent Director
Maria Shepherd is a seasoned global executive in the medical industry, serving as President & CEO of Medi-Vantage. With roles at Royal Dutch Philips, Oridion Medical, and Boston Scientific, she brings expertise in devices, diagnostics, and digital health. Maria is also a board member of MedExec Women, empowering female leaders in healthcare.
Pierre Beaudoin
Board Member
Pierre Beaudoin, with a tenure at Bombardier since 1985, became President and CEO in 2008. Known for his strategic leadership, he navigated the company through growth and expansion. Transitioning to Executive Chairman and Chairman of the Board, Beaudoin continues to shape Bombardier’s vision. He also serves on the boards of Power Corporation of Canada and BRP Inc.
Drew Trivisonno
Board Member
Drew Trivisonno is a seasoned investment professional with 20 years of experience in mergers & acquisitions, and debt & equity financing for medical device companies. He has a strong track record of completing successful deals with industry leaders and facilitating sales to Zimmer/Biomet and Stryker Corporation. Drew’s expertise includes sourcing, managing, negotiating transactions, and presenting to Boards.
Jose de la Cortina
Board Member
Jose De La Cortina is an accomplished sales leader known for expanding businesses globally. As Director of Sales for Europe and Japan at Baylis Medical, he played a key role in the company’s successful exit to Boston Scientific. With a track record of launching products and driving market share growth in the USA and Japan, he excels in building strong business relationships and achieving sales success.
Louis Laflamme
Board Member
Louis Laflamme, the President and CEO of Opsens, led the company to success in fiber optic sensors. Opsens recently sold to Haemonetics, marking a milestone in its growth. Laflamme’s leadership drove partnerships, expansions, and innovative sensor development, solidifying Opsens’ industry position.